|
FDA Updates on GLP-1 Medications - February 2026
|
|
0
|
13
|
February 16, 2026
|
|
Compounded vs Brand Semaglutide: What You Need to Know
|
|
2
|
19
|
February 9, 2026
|
|
⚠️ FDA Update on GLP-1 Compounding - What Businesses Need to Know
|
|
1
|
11
|
February 9, 2026
|
|
Understanding Peptide Research - A Beginner's Guide
|
|
1
|
17
|
February 9, 2026
|
|
Storage and Handling Basics for Peptide Research
|
|
1
|
13
|
February 7, 2026
|
|
Titration Schedules: What's Working for the Community?
|
|
3
|
12
|
February 7, 2026
|
|
📋 Official FDA Update: GLP-1 Safety Review Results (Jan 2026)
|
|
2
|
18
|
February 7, 2026
|
|
How Semaglutide Actually Works: The Science Made Simple
|
|
0
|
1
|
February 6, 2026
|
|
Stacking Protocols - What Combinations Are People Researching?
|
|
1
|
9
|
February 5, 2026
|
|
3 Months on Semaglutide - My Honest Experience (The Good AND Bad)
|
|
1
|
25
|
February 5, 2026
|
|
Beyond GLP-1s: BPC-157, TB-500 & Research Peptides for Recovery
|
|
0
|
15
|
February 5, 2026
|
|
Managing GLP-1 Side Effects: Community Tips & Strategies
|
|
0
|
5
|
February 5, 2026
|
|
Semaglutide vs Tirzepatide: Side-by-Side Comparison from Research Data
|
|
0
|
13
|
February 5, 2026
|
|
Reconstitution Best Practices - BAC Water, Storage & Handling Guide
|
|
0
|
23
|
February 4, 2026
|
|
GLP-1 & Peptides FAQ - Semaglutide, Tirzepatide, Dosing & Results Guide
|
|
0
|
27
|
February 4, 2026
|
|
Hexarelin – Research Overview
|
|
0
|
10
|
February 2, 2026
|
|
Ipamorelin – Research Overview
|
|
0
|
22
|
February 2, 2026
|
|
Kisspeptin – Research Overview
|
|
0
|
12
|
February 2, 2026
|
|
KPV – Research Overview
|
|
0
|
17
|
February 2, 2026
|
|
L-Carnitine – Research Overview
|
|
0
|
5
|
February 2, 2026
|
|
FOXO4-DRI (Proxofim) – Research Overview
|
|
0
|
52
|
November 15, 2025
|
|
Follistatin-344 – Research Overview
|
|
0
|
38
|
November 15, 2025
|
|
Epitalon – Research Overview
|
|
0
|
46
|
November 15, 2025
|
|
DSIP (Delta Sleep–Inducing Peptide) – Research Overview
|
|
0
|
51
|
November 15, 2025
|
|
Dihexa – Research Overview
|
|
0
|
39
|
November 15, 2025
|
|
CJC-1295 (No DAC) – Research Overview
|
|
0
|
88
|
November 15, 2025
|
|
CJC-1295 With DAC – Research Overview
|
|
0
|
54
|
November 15, 2025
|
|
Cagrilintide – Research Overview
|
|
0
|
55
|
November 15, 2025
|
|
Bremelanotide (PT-141) – Research Overview
|
|
0
|
49
|
November 15, 2025
|
|
Adipotide – Research Overview
|
|
0
|
33
|
November 15, 2025
|